Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Regulatory News (EVG)

  • There is currently no data for EVG

Form 8.5 (EPT/RI)

31 Oct 2011 10:45

RNS Number : 1420R
Bank of America Merrill Lynch
31 October 2011
 



FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING

IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose relevant securities this INVESTEC LTD

form relates:

(c) Name of the party to the offer with which exempt Advisor to INVESTEC PLC and INVESTEC LTD

principal trader is connected:

(d) Date dealing undertaken: 28/10/2011

(e) Has the EPT previously disclosed, or is it today disclosing, under the NO

Code in respect of any other party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - ZAE000081949 Purchase 41,310 ZAR 51.00 ZAR 50.00

Common - ZAE000081949 Sale 41,310 ZAR 50.49 ZAR 50.23

(b) Derivatives transactions (other than options)

Class of Product description Nature of dealing Number of reference  Price per unit

relevant securities

security

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

(ii) Exercising

Class of relevant security Product description Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing Details Price per unit (if applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 31/10/2011

Contact name: Balenkosi Dungeni

Telephone number: +44 20 7996 1639

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING

IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose relevant securities this Evolution Group Plc

form relates:

(c) Name of the party to the offer with which exempt Advisor to INVESTEC PLC and INVESTEC LTD

principal trader is connected:

(d) Date dealing undertaken: 28/10/2011

(e) Has the EPT previously disclosed, or is it today disclosing, under the NO

Code in respect of any other party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - GB0030221864 Purchase 24,398 GBP 0.89 GBP 0.88

Common - GB0030221864 Sale 10,160 GBP 0.89 GBP 0.88

(b) Derivatives transactions (other than options)

Class of Product description   Nature of dealing Number of reference   Price per unit

relevant eg. CFD securities

security

Common - GB0030221864 Swap SHORT 10668 GBP 0.89

Common - GB0030221864 Swap SHORT 6474 GBP 0.88

Common - GB0030221864 Swap SHORT 2863 GBP 0.88

Common - GB0030221864 Swap SHORT 2693 GBP 0.88

Common - GB0030221864 Swap SHORT 1700 GBP 0.88

Class of Product description   Nature of dealing Number of reference   Price per unit

relevant eg. CFD securities

security

Common - GB0030221864 Swap LONG 314 GBP 0.90

Common - GB0030221864 Swap LONG 1386 GBP 0.90

Common - GB0030221864 Swap LONG 2452 GBP 0.88

Common - GB0030221864 Swap LONG 2938 GBP 0.88

Common - GB0030221864 Swap LONG 3070 GBP 0.88

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

(ii) Exercising

Class of relevant security Product description Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing Details Price per unit (if applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 31/10/2011

Contact name: Balenkosi Dungeni

Telephone number: +44 20 7996 1639

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING

IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Name of exempt principal trader: Bank of America Merrill Lynch

(b) Name of offeror/offeree in relation to whose relevant securities this INVESTEC PLC

form relates:

(c) Name of the party to the offer with which exempt Advisor to INVESTEC PLC and INVESTEC LTD

principal trader is connected:

(d) Date dealing undertaken: 28/10/2011

(e) Has the EPT previously disclosed, or is it today disclosing, under the NO

Code in respect of any other party to this offer?

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a) Purchases and sales

Class of Purchase/ Total number Highest price Lowest price

relevant Sales of securities per unit per unit

security paid/received paid/received

Common - GB00B17BBQ50 Purchase 38,933 GBP 3.99 GBP 3.94

Common - GB00B17BBQ50 Sale 1,295 GBP 4.02 GBP 3.94

(b) Derivatives transactions (other than options)

Class of Product description   Nature of dealing Number of reference   Price per unit

relevant eg. CFD securities

security

Common - GB00B17BBQ50 Swap SHORT 21012 GBP 3.94

Common - GB00B17BBQ50 Swap SHORT 2441 GBP 3.99

Common - GB00B17BBQ50 Swap SHORT 1166 GBP 3.94 Common - GB00B17BBQ50 Swap SHORT 11212 GBP 3.97

Common - GB00B17BBQ50 Swap SHORT 715 GBP 3.95

Common - GB00B17BBQ50 Swap SHORT 825 GBP 3.99

Common - GB00B17BBQ50 Swap SHORT 599 GBP 3.95

Common - GB00B17BBQ50 Swap SHORT 445 GBP 3.95

Common - GB00B17BBQ50 Swap SHORT 137 GBP 3.99

Common - GB00B17BBQ50 Swap SHORT 116 GBP 3.96

Common - GB00B17BBQ50 Swap SHORT 104 GBP 3.96

Common - GB00B17BBQ50 Swap SHORT 84 GBP 3.96

Common - GB00B17BBQ50 Swap SHORT 77 GBP 3.96

Class of Product description   Nature of dealing Number of reference   Price per unit

relevant eg. CFD securities

security

Common - GB00B17BBQ50 Swap LONG 90 GBP 4.01

Common - GB00B17BBQ50 Swap LONG 360 GBP 4.02

Common - GB00B17BBQ50 Swap LONG 845 GBP 3.94

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Class of Product Writing, Number of Exercise Type Expiry Option

relevant description purchasing, securities price date money

security selling, to which per unit paid/

varying etc. option received

relates per unit

(ii) Exercising

Class of relevant security Product description Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing Details Price per unit (if applicable)

3. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the exempt principal trader making the

disclosure and any party to the offer or any person acting in concert with a party to the

offer:

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which

any derivative is referenced:

NONE

Date of disclosure: 31/10/2011

Contact name: Doug Berwick

Telephone number: +44 20 7995 8859

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERBFLFXFBFZFBZ
Date   Source Headline
22nd Mar 20217:00 amRNSAppointment of Chief Business Officer
15th Mar 20219:00 amRNSHolding(s) in Company
11th Mar 20217:00 amRNSUpdate on Data Safety Review - STAR COVID-19 trial
9th Mar 202111:35 amRNSHolding(s) in Company
8th Mar 20211:49 pmRNSHolding(s) in Company
5th Mar 20214:04 pmRNSHolding(s) in Company
5th Mar 20219:17 amRNSDirector dealing
3rd Mar 202112:10 pmRNSResult of General Meeting & Total Voting Rights
3rd Mar 20217:00 amRNSResult of Open Offer
26th Feb 20214:39 pmRNSHolding(s) in Company
17th Feb 20219:58 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSUpdate on patient recruitment
12th Feb 20217:00 amRNSPosting of Circular & Notice of GM
2nd Feb 20213:15 pmRNSPlacing and Open Offer to raise up to £11 million
22nd Jan 20217:00 amRNSPreclinical data on a new therapeutic target
21st Jan 20217:00 amRNSPositive pre-clinical data for lead asset SFX-01
19th Jan 20217:00 amRNSPatient recruitment update in STAR-COVID 19 trial
23rd Dec 20202:05 pmRNSSecond Price Monitoring Extn
23rd Dec 20202:00 pmRNSPrice Monitoring Extension
10th Dec 20207:00 amRNSHalf-year Report
27th Nov 20202:33 pmRNSHolding(s) in Company
27th Nov 20209:15 amRNSHolding(s) in Company
23rd Nov 20207:00 amRNSRecruitment of first patient in STAR trial
11th Nov 20207:00 amRNSComment on the COVID-19 vaccine announcement
6th Nov 20209:25 amRNSHolding(s) in Company
29th Oct 202011:55 amRNSHolding(s) in Company
29th Oct 20209:09 amRNSHolding(s) in Company
26th Oct 20203:00 pmRNSHolding(s) in Company
23rd Oct 20207:00 amRNSAll approvals received for STAR trial to commence
6th Oct 20207:00 amRNSGrant of options
24th Sep 20207:00 amRNSAppointment of Chief Executive Officer
15th Sep 20207:00 amRNSLicence agreement with Juvenescence
18th Aug 20203:30 pmRNSHolding(s) in Company
18th Aug 20203:25 pmRNSHolding(s) in Company
14th Aug 20204:41 pmRNSSecond Price Monitoring Extn
14th Aug 20204:35 pmRNSPrice Monitoring Extension
5th Aug 20204:41 pmRNSSecond Price Monitoring Extn
5th Aug 20204:35 pmRNSPrice Monitoring Extension
31st Jul 20203:40 pmRNSHolding(s) in Company
24th Jul 20209:47 amRNSShare option exercise and issue of equity
17th Jul 202012:05 pmRNSHolding(s) in Company
17th Jul 202012:02 pmRNSHolding(s) in Company
16th Jul 20202:52 pmRNSResult of AGM
7th Jul 202011:13 amRNSShare option exercise and issue of equity
6th Jul 20207:00 amRNSShare option exercise and issue of equity
23rd Jun 202011:44 amRNSHolding(s) in Company
23rd Jun 202011:38 amRNSHolding(s) in Company
19th Jun 20207:00 amRNSNotice of AGM
17th Jun 20209:38 amRNSHolding(s) in Company
17th Jun 20209:37 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.